Delivery Order SPE2DB20D1051-SPE2DB25FD8JC

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 10 MG CAPSULE 100S, a medication, with a ceiling value of $2,922.41 and a completion date of May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a neurological medication, with a ceiling value of $1,105.32 and a completion date of May 20, 2025. The contract is not set-aside and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a medication used to treat certain medical conditions. The contract has a ceiling value of $2,137.55 and a period of performance through June 5, 2025. It is a firm-fixed-price contract, indicating a predetermined price for the product. The contract is not designated as a...
This is a $1,543.45 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a period of performance through June 5, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,978.56 and a completion date of May 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication, to support federal healthcare programs. The contract has a ceiling value of $1,078.98 and runs through February 19, 2025. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open...
This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 10 MG CAPSULE 100S, a medication, with a ceiling value of $2,225.86. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of May 13, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,346.26 and a completion date of May 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of VYVANSE 30 MG CAPSULE 100S, a specialty medication, with a ceiling value of $11,366.74 and a period of performance through April 1, 2025. The contract is an Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,265,916 units of the medication VYVANSE 10 MG CAPSULE 100S, with a ceiling value of $1,320.90. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) with a period of performance through July 29, 2024. Amerisourcebergen is not operating under a set-aside designation for this award. This delivery...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD8JC
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 10 MG CAPSULE 100S, a neurological medication. The contract has a firm fixed price with a ceiling value of $1,929.06 and is set to expire on June 5, 2025. The contract is not a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract positions Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/3/25, 10:05 AM